Navigation Links
Frozen Yet Potent Viruses Found

Virus causing flu can survive for decades and longer, in frozen lakes and are very well capable of infecting humans and animals once again.//

Dr Scott Rogers of Bowling Green State University of Ohio and his team have found viral RNA perfectly preserved and still potent in a frozen lake of Siberia. Such frozen viruses can be picked up by migratory birds and are capable of causing outbreaks of viral diseases. Those viruses could even cause new epidemics that could sicken and kill many generations after they were last seen, so report researchers in the Journal of Virology.

Migrating birds are said to be the carriers of avian influenza (bird flu) that has spread into 50 countries and killed around 153 persons.

The virus, which causes avian influenza, H5N1 is a descendant of H1N1 that caused a pandemic in 1918, leaving around 40 to 100 million persons dead. This virus was recovered from the frozen body of a victim in Alaska. Were that strain of H1N1 to circulate today, it could cause another serious pandemic because no one alive now has immunity to it, Rogers said.

Dr. Rogers and his team had also discovered a strain of H1 virus that circulated during the late 1930s and 1960s.

The data taken from the study of Dr. Rogers and his team suggested that influenza A virus deposited as the birds begin their autumn migration could be preserved in lake ice and released as the ice melted. This in turn could be picked up again by migrating birds and spread along their paths of flight.
SRM
'"/>




Page: 1

Related medicine news :

1. Frozen Canadian baby stages miraculous recovery
2. Frozen food invite food poisoning
3. Baby Born Through Frozen Donor Egg
4. Frozen fish is costly and also lacks vital nutrients
5. Frozen embryos stored in Britain
6. Salmonella Poisoned Frozen Pasta Hit Six
7. Brain-Damaged Girl Frozen in Time to Remain Child-Sized Forever
8. Not to Be Frozen
9. Californian Baby Creates History - Born from a Frozen Egg and Sperm
10. Potential New Cancer Gene Identified
11. Lack of Smell And Its Potential Risks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2017)... , ... May 24, 2017 , ... ... of ExtraHop to its solutions portfolio. ExtraHop delivers an analytics-first approach, layered with ... every IT system, from the datacenter to the cloud to the edge. Through ...
(Date:5/24/2017)... ... 24, 2017 , ... The CFOs included on this list ... in the nation and help their organizations navigate the challenges in healthcare today. ... in developing successful hospital and health system strategy. , Becker's Hospital Review has ...
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand International (MDLand), a ... today that its iClinic V12.2 solution has achieved approval from National Center for ... PCMH 2017 standards which emphasize team-based care with a significant focus on the ...
(Date:5/23/2017)... ... May 23, 2017 , ... Cambridge, MA, May ... since 2009, according to a Workers Compensation Research Institute (WCRI) study, a contrast ... North Carolina System: CompScope™ Benchmarks, 17th Edition looks at indemnity and medical ...
(Date:5/23/2017)... ... 2017 , ... London, May 23, 2017: Walter Schindler, the Founder and Managing ... Guest Speaker and Contributor to a weeklong series of classes, meetings, field trips and ... , Walter Schindler and SAIL Capital have received an increasing number ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)... -- Bayer announced today that the latest research from across ... 53 rd Annual Meeting of the American Society ... Chicago . The ... and thyroid cancers, as well as lymphomas, and includes ... of copanlisib in patients with relapsed or refractory follicular ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: